Pfizer cuts 2012 sales forecast, shares fall

NEW YORK (Reuters) - Pfizer Inc cut its sales projection for 2012, the first full year its $10 billion-a-year Lipitor cholesterol fighter faces competition from cheaper U.S. generics, sending its...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.